From Green Success to BH Labs: Why the Next Cannabis Leaders Will Look More Like Technology Companies
As Europe’s medical cannabis market matures, a new category of operator is beginning to emerge.
As Europe’s medical cannabis market matures, a new category of operator is beginning to emerge.
This morning, the latest in a now-weekly series of stories in the British mainstream press was published in The Times, for the second week in a row taking aim at the advertising practices of some of the UK’s largest clinics.
The UK economic growth faces a paradox of two seemingly opposing pressures, yet both may be resolved by moving in the same direction.
EXTINCTION EVENT? C4 Distribution shuts down after failing to raise money A memo signed by C4 CEO Eric Spitz says that due to lack of financing, California’s C4 cannabis company is ceasing operations, reports Insider.
THE Member of Parliament sponsoring the Medical Cannabis Access Bill in the House of Commons today has acknowledged it is set to fail due to lack of political support.
INTERCURE, which calls itself the ‘most profitable and fastest growing’ cannabis company outside of North America, is poised to open a number of cannabis shops on UK high streets.
CONSERVATIVE MPs have blocked efforts to boost UK medical cannabis access with the Government saying the existing legislation is sufficient.
GLASS Pharms has agreed a £22.5m funding deal to build the UK mainland’s first, high-THC, commercial cultivation facility for over 20 years.
A CAMPAIGN group is calling for a review of the way drug driving is tackled and a return to pre-2015 legislation following a dramatic increase in the number of cannabis users convicted since the law was changed six years ago.